Search

Search Constraints

You searched for: Author/Creator Doukas, M

Search Results

1. 453. THE EFFECTIVITY OF NEOADJUVANT CHEMORADIOTHERAPY IN ESOPHAGEAL ADENOCARCINOMA WITH PRESENCE OF EXTRACELLULAR MUCINE, SIGNET-RING CELLS OR POORLY COHESIVE CELLS. (24th September 2022)

2. Adherence to pre-set benchmark quality criteria to qualify as expert assessor of dysplasia in Barrett's esophagus biopsies – towards digital review of Barrett's esophagus. Issue 7 (August 2019)

3. Adherence to pre‐set benchmark quality criteria to qualify as expert assessor of dysplasia in Barrett's esophagus biopsies – towards digital review of Barrett's esophagus. Issue 7 (1st August 2019)

4. P064 High intestinal Secretory Leukocyte Protease Inhibitor (SLPI) expression correlates with abundant neutrophilic inflammation and identifies Inflammatory Bowel Disease patients with a strong IL-17 response. (30th January 2023)

5. P069 Elevated adaptive immune responses to multiple Lachnospiraceae bacterial flagellins in therapy-naïve pediatric CD patients are associated with distinct immune pathology. (30th January 2023)

6. P284 Prophylactic medication for the prevention of endoscopic recurrence after ileocolonic resection in Crohn's disease: a prospective study based on clinical risk stratification. (21st January 2022)

7. P555 Ustekinumab tissue and serum levels in patients with Crohn's disease are closely correlated though not consistently associated with objective response after induction. (21st January 2022)

8. P84 LOCALIZATION OF UNDETECTED RESIDUAL TUMOR AFTER NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH ESOPHAGEAL CANCER. (23rd November 2019)

9. Residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer: locations undetected by endoscopic biopsies in the preSANO trial. Issue 13 (5th August 2020)

10. Safety and efficacy of transarterial embolization of hepatocellular adenomas. Issue 10 (17th July 2019)